Effect of diosmin on the intestinal absorption and pharmacokinetics of fexofenadine in rats

Middleton, 2000, The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer, Pharmacol Rev, 52, 673

Romano, 2013, Novel insights into the pharmacology of flavonoids, Phytother Res, 27, 1588, 10.1002/ptr.5023

Zhang, 2003, Effects of the flavonoids biochanin A, morin, phloretin, and silymarin on P-glycoprotein-mediated transport, J Pharmacol Exp Ther, 304, 1258, 10.1124/jpet.102.044412

Kim, 2010, Effects of silybinin on the pharmacokinetics of tamoxifen and its active metabolite, 4-hydroxytamoxifen in rats, Anticancer Res, 30, 79

Cho, 2011, Effects of the antioxidant baicalein on the pharmacokinetics of nimodipine in rats: a possible role of P-glycoprotein and CYP3A4 inhibition by baicalein, Pharmacol Rep, 63, 1066, 10.1016/S1734-1140(11)70624-7

Sridhar, 2014, Evaluation of first-pass cytochrome P4503A (CYP3A) and P-glycoprotein activities using felodipine and hesperetin in combination in wistar rats and everted rat gut sacs in vitro, Phytother Res, 28, 699, 10.1002/ptr.5040

Brand, 2006, Flavonoid-mediated inhibition of intestinal ABC transporters may affect the oral bioavailability of drugs, food-borne toxic compounds and bioactive ingredients, Biomed Pharmacother, 60, 508, 10.1016/j.biopha.2006.07.081

Di Pietro, 2002, Modulation by flavonoids of cell multidrug resistance mediated by P-glycoprotein and related ABC transporters, Cell Mol Life Sci, 59, 307, 10.1007/s00018-002-8424-8

Qiu, 2009, Effect of berberine on the pharmacokinetics of substrates of CYP3A and P-gp, Phytother Res, 23, 1553, 10.1002/ptr.2808

Pathak, 2010, Pre-clinical evidence of enhanced oral bioavailability of the P-glycoprotein substrate talinolol in combination with morin, Biopharm Drug Dispos, 31, 202

Pari, 2010, Antihyperglycemic effect of diosmin on hepatic key enzymes of carbohydrate metabolism in streptozotocin-nicotinamide-induced diabetic rats, Biomed Pharmacother, 64, 477, 10.1016/j.biopha.2010.02.001

Yoo, 2007, Effects of diosmin, a flavonoid glycoside in citrus fruits, on P-glycoprotein-mediated drug efflux in human intestinal Caco-2 cells, J Agric Food Chem, 55, 7620, 10.1021/jf070893f

Ambudkar, 1999, Biochemical, cellular, and pharmacological aspects of the multidrug transporter, Annu Rev Pharmacol Toxicol, 39, 361, 10.1146/annurev.pharmtox.39.1.361

Matheny, 2001, Pharmacokinetic and pharmacodynamic implications of P-glycoprotein modulation, Pharmacotherapy, 21, 778, 10.1592/phco.21.9.778.34558

Simpson, 2000, Fexofenadine: a review of its use in the management of seasonal allergic rhinitis and chronic idiopathic urticaria, Drugs, 59, 301, 10.2165/00003495-200059020-00020

Jin, 2010, Effect of piperine, a major component of black pepper, on the intestinal absorption of fexofenadine and its implication on food–drug interaction, J Food Sci, 75, 93, 10.1111/j.1750-3841.2010.01542.x

Ruan, 2006, Prediction of human absorption of natural compounds by the non-everted rat intestinal sac model, Eur J Med Chem, 41, 605, 10.1016/j.ejmech.2006.01.013

Wada, 2013, The role of inter-segmental differences in P-glycoprotein expression and activity along the rat small intestine in causing the double-peak phenomenon of substrate plasma concentration, Drug Metab Pharmacokinet, 28, 98, 10.2133/dmpk.DMPK-12-RG-005

Salphati, 2001, Evaluation of a single-pass intestinal-perfusion method in rat for the prediction of absorption in man, J Pharm Pharmacol, 53, 1007, 10.1211/0022357011776252

Varma, 2005, Prediction of in vivo intestinal absorption enhancement on P-glycoprotein inhibition, from rat in situ permeability, J Pharm Sci, 94, 1694, 10.1002/jps.20309

Neerati, 2011, Study on in situ and in vivo absorption kinetics of phenytoin by modulating P-glycoprotein with verapamil in rats, Eur J Pharm Sci, 44, 27, 10.1016/j.ejps.2011.05.005

Sutton, 2001, Comparison of the gravimetric, phenol red and 14C-PEG-3350 methods to determine water absorption in the rat single-pass intestinal perfusion model, AAPS Pharm Sci, 3, E25, 10.1208/ps030325

Walter-Sack, 1996, Influence of diet and nutritional status on drug metabolism, Clin Pharmacokinet, 31, 47, 10.2165/00003088-199631010-00004

Evans, 2000, Influence of dietary components on the gastrointestinal metabolism and transport of drugs, Ther Drug Monit, 22, 131, 10.1097/00007691-200002000-00028

Zhou, 2004, Herbal modulation of P-glycoprotein, Drug Metab Rev, 36, 57, 10.1081/DMR-120028427

Takara, 2003, Expression profiles of drug-metabolizing enzyme CYP3A and drug efflux transporter multidrug resistance 1 subfamily mRNAS in small intestine, Drug Metab Dispos, 31, 1235, 10.1124/dmd.31.10.1235

Yamazaki, 2001, In vitro substrate identification studies for p-glycoprotein-mediated transport: species difference and predictability of in vivo results, J Pharmacol Exp Ther, 296, 723

Chiou, 1998, Linear correlation of the fraction of oral dose absorbed of 64 drugs between humans and rats, Pharm Res, 15, 1792, 10.1023/A:1011981317451

Kaul, 1981, Studies of the intestinal transfer of coumarin and 7-hydroxycoumarin across guinea pig and rat small intestine, Arzneimittelforschung, 31, 790

Genty, 2001, Determination of the passive absorption through the rat intestine using chromatographic indices and molar volume, Eur J Pharm Sci, 12, 223, 10.1016/S0928-0987(00)00175-5